Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2025)

Marimed has reported Asset Writedowns and Impairment over the past 6 years, most recently at $60000.0 for Q4 2025.

  • Quarterly Asset Writedowns and Impairment rose 129.27% to $60000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 570.83% year-over-year, with the annual reading at $1.6 million for FY2025, 570.83% up from the prior year.
  • Asset Writedowns and Impairment was $60000.0 for Q4 2025 at Marimed, up from -$122000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.4 million in Q1 2025 and troughed at -$205000.0 in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $37500.0 (2021), against an average of $204125.0.
  • Year-over-year, Asset Writedowns and Impairment tumbled 405.0% in 2023 and then skyrocketed 1806.67% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $7000.0 in 2021, then soared by 471.43% to $40000.0 in 2022, then soared by 512.5% to $245000.0 in 2023, then tumbled by 183.67% to -$205000.0 in 2024, then surged by 129.27% to $60000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Asset Writedowns and Impairment are $60000.0 (Q4 2025), -$122000.0 (Q3 2025), and $256000.0 (Q2 2025).